Combination of stereotactic ablative body radiation with targeted therapies.

Zeng, Jing; Baik, Christina; Bhatia, Shailender; Mayr, Nina; Rengan, Ramesh

Zeng, Jing; Baik, Christina; Bhatia, Shailender; Mayr, Nina; Rengan, Ramesh.

Zeng J; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
Baik C; Department of Medicine (Medical Oncology Division), University of Washington School of Medicine, Seattle, WA, USA.
Bhatia S; Department of Medicine (Medical Oncology Division), University of Washington School of Medicine, Seattle, WA, USA.
Mayr N; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
Rengan R; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: rengan@uw.edu.

Lancet Oncol ; 15(10): e426-34, 2014 Sep.

Article en En | MEDLINE | ID: mdl-25186046

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/cirugía; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/cirugía; Terapia Molecular Dirigida/métodos; Radiocirugia/métodos; Inhibidores de la Angiogénesis/uso terapéutico; Carcinoma de Pulmón de Células no Pequeñas/patología; Terapia Combinada; Femenino; Estudios de Seguimiento; Humanos; Neoplasias Pulmonares/patología; Masculino; Proteínas Tirosina Quinasas/antagonistas & inhibidores; Medición de Riesgo; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radiocirugia / Carcinoma de Pulmón de Células no Pequeñas / Terapia Molecular Dirigida / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google